The Latest Breaking News from diabetes

A new study out this week suggests that sticking to the diet could even help improve beta-cell function in people with type 2 diabetes.

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…

Doctors and NHS England’s chief warned this week demand for weight-loss jabs could overwhelm the health services

Diabetes medications have started to gain attention for something other than their intended purpose: weight loss. Originally designed to manage blood sugar levels in patients with diabetes, these medications are now proving to be effective tools in the fight against obesity. As research grows, the narrative surrounding these drugs has…

Population and animal studies suggested metformin could treat cancer, but the clinical trials were a bust. Here’s what happened and what potential may remain.

Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners

Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.

The Our Future Health programme aims to transform the prevention, detection and treatment of conditions like dementia, cancer, and diabetes.

The study noted an increased risk of type 2 diabetes in pediatric patients after a bout of COVID-19 infection compared to other respiratory infections.